Jay Lugthart
General Practice · Jenison, MINPI 1215059241
Payments from drug & device makers
Across 318 payments — averaging $22.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Novo Nordisk$919
- Lilly USA, LLC$443
- Amgen$434
- GSK$417
- Johnson & Johnson$401
- plus $2K from 23 others
What the payments were for
- Food & beverage$6,94699%
- Education$771%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 55 | $2,482 |
| Novo Nordisk | 64 | $919 |
| Lilly USA, LLC | 24 | $443 |
| Amgen | 22 | $434 |
| GSK | 39 | $417 |
| Johnson & Johnson | 14 | $401 |
| AbbVie(2 entities) | 15 | $392 |
| Amarin Pharma, Inc. | 11 | $249 |
| Novartis | 7 | $212 |
| Boehringer Ingelheim | 13 | $166 |
| Merck | 9 | $134 |
| Bayer | 5 | $122 |
| Teva Pharmaceuticals USA, Inc. | 8 | $118 |
| Biohaven Pharmaceuticals, Inc. | 4 | $84 |
| Sanofi-aventis U.S. LLC | 5 | $74 |
| Paratek Pharmaceuticals, Inc. | 2 | $44 |
| Supernus Pharmaceuticals, Inc. | 3 | $42 |
| E.r. Squibb & Sons, L.L.C. | 3 | $40 |
| Eisai Inc. | 2 | $38 |
| Nabriva Therapeutics, PLC | 2 | $32 |
| Exact Sciences | 2 | $26 |
| Vanda Pharmaceuticals Inc. | 1 | $26 |
| Promius Pharma LLC | 1 | $25 |
| Pfizer | 2 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| Astellas Pharma US Inc | 1 | $19 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $17 |
| Esperion Therapeutics, Inc. | 1 | $13 |
| Antares Pharma, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,023 in reported general payments places this provider in the 95th percentile of 3,051 general practice providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 24 | $30,791 |
| EliquisApixaban | 17 | $26,698 |
| XareltoRivaroxaban | 16 | $21,252 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 26 | $20,244 |
| TrulicityDulaglutide | 11 | $14,797 |
| Atorvastatin Calcium | 119 | $2,484 |
| Metoprolol Succinate | 81 | $2,249 |
| Omeprazole | 78 | $1,736 |
| Rosuvastatin Calcium | 76 | $1,663 |
| Losartan Potassium | 62 | $1,417 |
| Levothyroxine Sodium | 45 | $986 |
| Lisinopril | 59 | $940 |
| Amlodipine Besylate | 89 | $919 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 19 | $826 |
| Ezetimibe | 21 | $748 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga | $2,482 | $30,79124 claims |
| PfizerEliquis | $23 | $26,69817 claims |
| Johnson & JohnsonXarelto | $401 | $21,25216 claims |
| GSKTrelegy Ellipta | $417 | $20,24426 claims |
| Lilly USA, LLCTrulicity | $443 | $14,79711 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,051 general practice providers in Michigan.
Other general practice in Jenison
- John McMahonJenison$11K
- Anil PrasadTaylor$1.7M
- Sadeer DaoodDearborn$1.1M
- Shakib HalabuWest Bloomfield$1.1M
- Dennis FasbinderAnn Arbor$758K
- Christian GrothAnn Arbor$283K
- Kevin BoneSaginaw$125K
- David JulianiRochester Hills$106K
- Marie FluentAnn Arbor$106K
- Howard KormanRoyal Oak$93K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.